{"id":31055,"date":"2018-02-14T12:00:00","date_gmt":"2018-02-14T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/"},"modified":"2018-02-14T12:00:00","modified_gmt":"2018-02-14T12:00:00","slug":"immunotherapie-allergenique-peut-on-prevenir-lasthme","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/","title":{"rendered":"Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ?"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1489 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Bruxelles 2017<\/h2>\n<p>La pr\u00e9vention de l\u2019asthme chez les patients atteints de rhinite allergique est possible ; toutefois, il n\u2019existe pas d\u2019effet de classe g\u00e9n\u00e9rique, de sorte que les experts du domaine ne peuvent pas confirmer que tous les produits d\u2019ITA peuvent atteindre cet objectif. Les donn\u00e9es probantes montrent, \u00e0 ce jour, des limites, mais une \u00e9tude \u00e0 long terme de Mola, portant sur l\u2019immunoth\u00e9rapie allerg\u00e9nique chez des enfants allergiques au pollen de gramin\u00e9es, a montr\u00e9 que ceux qui avaient re\u00e7u le traitement \u00e9taient moins susceptibles de d\u00e9velopper un asthme. <\/p>\n<p>Ces entretiens ont \u00e9t\u00e9 enregistr\u00e9s lors des Rhinology Future Debates Bruxelles 2017 avec Oliver Pfaar, David Price et Glenis Scadding.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1490 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/fDb7aQAp4zI?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Bruxelles 2017 La pr\u00e9vention de l\u2019asthme chez les patients atteints de rhinite allergique est possible ; toutefois, il n\u2019existe pas d\u2019effet de classe g\u00e9n\u00e9rique, de sorte que les experts du domaine ne peuvent pas confirmer que tous les produits d\u2019ITA peuvent atteindre cet objectif. Les donn\u00e9es probantes montrent, \u00e0 ce jour, des limites, mais une \u00e9tude \u00e0 long terme de Mola, portant sur l\u2019immunoth\u00e9rapie allerg\u00e9nique chez des enfants allergiques au pollen de gramin\u00e9es, a montr\u00e9 que ceux qui avaient re\u00e7u le traitement \u00e9taient moins susceptibles de d\u00e9velopper un asthme. Ces entretiens ont \u00e9t\u00e9 enregistr\u00e9s lors des Rhinology Future Debates Bruxelles 2017 avec Oliver Pfaar, David Price et Glenis Scadding.<\/p>\n","protected":false},"author":1,"featured_media":31068,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[189],"tags":[191,192,248,269,170,172,190],"class_list":["post-31055","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-debats","tag-rhinology-future-debates","tag-immunotherapie-allergenique-ita","tag-rhinite-allergique-ra","tag-professionnels-de-sante","tag-asthme","tag-rhinologie"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ? - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ?\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Bruxelles 2017 La pr\u00e9vention de l\u2019asthme chez les patients atteints de rhinite allergique est possible ; toutefois, il n\u2019existe pas d\u2019effet de classe g\u00e9n\u00e9rique, de sorte que les experts du domaine ne peuvent pas confirmer que tous les produits d\u2019ITA peuvent atteindre cet objectif. Les donn\u00e9es probantes montrent, \u00e0 ce jour, des limites, mais une \u00e9tude \u00e0 long terme de Mola, portant sur l\u2019immunoth\u00e9rapie allerg\u00e9nique chez des enfants allergiques au pollen de gramin\u00e9es, a montr\u00e9 que ceux qui avaient re\u00e7u le traitement \u00e9taient moins susceptibles de d\u00e9velopper un asthme. Ces entretiens ont \u00e9t\u00e9 enregistr\u00e9s lors des Rhinology Future Debates Bruxelles 2017 avec Oliver Pfaar, David Price et Glenis Scadding.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-peut-on-prevenir-lasthme\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-peut-on-prevenir-lasthme\\\/\",\"name\":\"Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ? - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-peut-on-prevenir-lasthme\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-peut-on-prevenir-lasthme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png\",\"datePublished\":\"2018-02-14T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-peut-on-prevenir-lasthme\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-peut-on-prevenir-lasthme\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-peut-on-prevenir-lasthme\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-peut-on-prevenir-lasthme\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ? - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/","og_locale":"fr_FR","og_type":"article","og_title":"Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ?","og_description":"Rhinology Future Debates Bruxelles 2017 La pr\u00e9vention de l\u2019asthme chez les patients atteints de rhinite allergique est possible ; toutefois, il n\u2019existe pas d\u2019effet de classe g\u00e9n\u00e9rique, de sorte que les experts du domaine ne peuvent pas confirmer que tous les produits d\u2019ITA peuvent atteindre cet objectif. Les donn\u00e9es probantes montrent, \u00e0 ce jour, des limites, mais une \u00e9tude \u00e0 long terme de Mola, portant sur l\u2019immunoth\u00e9rapie allerg\u00e9nique chez des enfants allergiques au pollen de gramin\u00e9es, a montr\u00e9 que ceux qui avaient re\u00e7u le traitement \u00e9taient moins susceptibles de d\u00e9velopper un asthme. Ces entretiens ont \u00e9t\u00e9 enregistr\u00e9s lors des Rhinology Future Debates Bruxelles 2017 avec Oliver Pfaar, David Price et Glenis Scadding.","og_url":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/","url":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/","name":"Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ? - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png","datePublished":"2018-02-14T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_20Can20asthma20prevention20be20achieved3F.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-peut-on-prevenir-lasthme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/fr\/news\/"},{"@type":"ListItem","position":3,"name":"Immunoth\u00e9rapie allerg\u00e9nique : peut-on pr\u00e9venir l\u2019asthme ?"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/fr\/#website","url":"https:\/\/www.euforea.org\/fr\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/fr\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/31055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=31055"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/31055\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/31068"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=31055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=31055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=31055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}